SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Serena Martire, Nicole D. Navone, Francesca Montarolo, Simona Perga, Antonio Bertolotto, A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients, Journal of Neuroimmunology, 2016, 292, 34

    CrossRef

  2. 2
    Lidia Fernández-Paredes, Rebeca Pérez de Diego, Clara de Andrés, Silvia Sánchez-Ramón, Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis, Molecular Neurobiology, 2016,

    CrossRef

  3. 3
    Angelika Bauer, Dagmar Rudzki, Michael Auer, Harald Hegen, Florian Deisenhammer, Expression of interferon type-I receptor isoforms, clinical response, and development of neutralizing antibodies in multiple sclerosis patients – results of a prospective study, LaboratoriumsMedizin, 2015, 0, 0

    CrossRef

  4. 4
    S. Malhotra, J. Rio, E. Urcelay, R. Nurtdinov, M. F. Bustamante, O. Fernandez, B. Oliver, U. Zettl, D. Brassat, J. Killestein, J. Lechner-Scott, J. Drulovic, A. Chan, F. Martinelli-Boneschi, A. Garcia-Merino, X. Montalban, M. Comabella, NLRP3 inflammasome is associated with the response to IFN-  in patients with multiple sclerosis, Brain, 2015, 138, 3, 644

    CrossRef

  5. 5
    Antonella D'Ambrosio, Simona Pontecorvo, Tania Colasanti, Silvia Zamboni, Ada Francia, Paola Margutti, Peripheral blood biomarkers in multiple sclerosis, Autoimmunity Reviews, 2015, 14, 12, 1097

    CrossRef

  6. 6
    M. F. Bustamante, C. Morcillo-Suarez, S. Malhotra, J. Rio, L. Leyva, O. Fernandez, U. K. Zettl, J. Killestein, D. Brassat, J. A. Garcia-Merino, A. J. Sanchez, E. Urcelay, R. Alvarez-Lafuente, L. M. Villar, J. C. Alvarez-Cermeno, X. Farre, J. Lechner-Scott, K. Vandenbroeck, A. Rodriguez-Antiguedad, J. S. Drulovic, F. Martinelli Boneschi, A. Chan, J. Oksenberg, A. Navarro, X. Montalban, M. Comabella, Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN- , Neurology: Neuroimmunology & Neuroinflammation, 2015, 2, 5, e154

    CrossRef

  7. 7
    Violaine K. Harris, Saud A. Sadiq, Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status, Molecular Diagnosis & Therapy, 2014, 18, 6, 605

    CrossRef

  8. 8
    Masaaki Niino, Yusei Miyazaki, Individualizing therapy for multiple sclerosis: a focus on disease-modifying drugs, Clinical Practice, 2014, 11, 1, 105

    CrossRef

  9. 9
    M. V. Ivanova, A. I. Tukhvatulin, A. Sh. Dzharullaeva, D. Yu. Logunov, M. N. Zakharova, Myelin lipids in the development of the autoimmune response in multiple sclerosis, Neurochemical Journal, 2014, 8, 4, 231

    CrossRef

  10. 10
    Yu Liu, Heng Yin, Ming Zhao, Qianjin Lu, TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review, Clinical Reviews in Allergy & Immunology, 2014, 47, 2, 136

    CrossRef

  11. 11
    María José Mansilla, Manuel Comabella, Jordi Río, Joaquín Castilló, Mireia Castillo, Roland Martin, Xavier Montalban, Carmen Espejo, Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients, Autoimmunity, 2014, 47, 2, 127

    CrossRef

  12. 12
    Cornelis L. Verweij, Brandon W. Higgs, Yihong Yao, Genomic Biomarkers for Pharmaceutical Development, 2014,

    CrossRef

  13. 13
    Giulio Podda, Mukanthu Nyirenda, James Crooks, Bruno Gran, Innate Immune Responses in the CNS: Role of Toll-Like Receptors, Mechanisms, and Therapeutic Opportunities in Multiple Sclerosis, Journal of Neuroimmune Pharmacology, 2013, 8, 4, 791

    CrossRef

  14. 14
    S. Malhotra, C. Morcillo-Suárez, R. Nurtdinov, J. Rio, E. Sarro, M. Moreno, J. Castilló, A. Navarro, X. Montalban, M. Comabella, Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment, European Journal of Neurology, 2013, 20, 10
  15. 15
    Pablo Villoslada, Sergio Baranzini, Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis, Journal of Neuroimmunology, 2012, 248, 1-2, 58

    CrossRef

  16. 16
    Alexander Hundeshagen, Michael Hecker, Brigitte Paap, Charlotte Angerstein, Ole Kandulski, Christian Fatum, Christiane Hartmann, Dirk Koczan, Hans-Juergen Thiesen, Uwe Zettl, Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance, Journal of Neuroinflammation, 2012, 9, 1, 140

    CrossRef

  17. 17
    Cornelis L Verweij, Research Highlights: Clinical relevance of the type I interferon signature in multiple sclerosis, Pharmacogenomics, 2012, 13, 16, 1883

    CrossRef

  18. 18
    Pierre-Antoine Gourraud, Hanne F. Harbo, Stephen L. Hauser, Sergio E. Baranzini, The genetics of multiple sclerosis: an up-to-date review, Immunological Reviews, 2012, 248, 1